Survival based on dynamic GA-MDC recommendation. PFS and OS among patients receiving CD19-directed or BCMA–directed CAR-T therapy stratified by GA-MDC dynamic recommendation (“proceed” vs “decline”). Deferred or declined patients successfully completing optimization recommendations that constituted the initial barrier were reclassified as proceed for the dynamic GA-MDC recommendation. All others were classified as declined.